搜索
DOI10．3877/cma．j．issn．1674－134X．2015．01．029510120··1。。。2014、1。Esposito2SIMIT。。AAOS、3、IDSA45、Tande6Shuman7、、。。、1．8。2．1289、、、、。、/、。3．212、、34。、1．、20%。80%12810。2．Waldvogel’s、、。121112。Cierny-Mader’s、/、、、1213。3．1。39.8%37.8%MＲSA114、。。121516。、、11617。90%、、、12616。。、、、12。4．、、。1。。、、、。、。。。、·821·2015291ChinJJointSurgElectronicEditionFebruary2015Vol．9No．1、。115。5．2WBC、ESＲCCＲP。ESＲCＲP21819。220。WBC15×109/L。WBC、ESＲCＲP。6．2。2。、。50%～70%。。CTMＲI。－992d。90%。60%～80%21。A-Ⅰ22122。FDG-PETCT223。7．11、。、、。A-Ⅲ。2、CBC、ESＲ、CCＲPA-Ⅲ。3MＲIA-Ⅰ。4、A-Ⅲ。5。A-Ⅱ。B-Ⅱ。8．11、A-Ⅰ、A-Ⅱ。A-Ⅲ、、、、。、、、A-Ⅲ。Cierny-Mader’s4～6。2～46～12B-Ⅲ。A-Ⅰ。ESＲ、CＲPA-Ⅲ。21。A-ⅠC-Ⅲ。MＲSAC-Ⅲ。、A-Ⅱ。MSSAA-ⅠMＲSAB-Ⅱ15～20μg/mlB-Ⅲ。B-Ⅱ。32、、。224。A-Ⅲ225。70%。226。。、、PMMA、、、。、225。。、、、227。4228－30。、85%B-Ⅲ。1．、、、、、、≥80、HIV、、13132。2．60%～90%133-36。4.5%～64%13738。MＲSACA-MＲSA13940。3．、、213741。133。60%14222%、13124。4．11A-Ⅱ、WBCA-Ⅱ、PCＲC-Ⅲ、B-Ⅲ、A-Ⅱ。2UAB-Ⅱ。A-Ⅱ。WBC、CBC、ESＲ、CＲPA-Ⅱ1。ESＲCＲPCＲP243-45。31A-Ⅲ。5．1。MＲI·921·2015291ChinJJointSurgElectronicEditionFebruary2015Vol．9No．1、B-Ⅱ。B-Ⅲ。6．、。7．11A-Ⅱ。4～62C-Ⅲ1。、/MＲSA。2A-Ⅱ。324～48hA-Ⅲ。4ESＲ、CＲPC-Ⅲ。prostheticjointinfectionPJI1．、267。1.7%2.5%3.2%、5.6%24647。、、、、、、、246-51。2．、、252。34～63～222。3．30%～43%12%～23%10%～11%、9%～10%/G-3%～6%、3%～7%2%～4%11%9。12。4．、、、、5053-56。、PJIB-Ⅲ2。5．ESＲCCＲP21819。220。257。ESＲCＲPPJIA-Ⅲ243-45。、、。＞1.7×103/L、＞65%94%、97%88%、98%A-II258。82%～94%94%～97%243455960。80%90%A-Ⅱ261-63。B-Ⅲ4。PCＲPJI26465。6．、、3～6266-68。CT269。MＲI220。270。7．。、、26。8．、/、、、、2457。、30d、3DAIＲA-Ⅱ2。12810。1MＲSA±MＲSA、、±22PJI。2。2、。2～34～62。3IDSAPJIDAIＲ/3～6A-Ⅰ2～6DAIＲA-ⅠC-Ⅲ4～6B-Ⅲ4～6A-Ⅱ/、C-Ⅲ45。1AⅠBⅡCⅢ1KoreanSocietyforChemotherapy．ClinicalguidelinesfortheantimicrobialtreatmentofboneandjointinfectionsinKoreaJ．InfectChemother201446125－138．2EspositoSILeoneSBassettiMetal．ItalianguidelinesforthediagnosisandinfectiousdiseasemanagementofosteomyelitisandprostheticjointinfectionsinadultsJ．Infection200937478－496．3DellaValleCParviziJBauerTWetal．AmericanAcademyof·031·2015291ChinJJointSurgElectronicEditionFebruary2015Vol．9No．1OrthopaedicSurgeonsclinicalpracticeguidelineonthediagnosisofperiprostheticjointinfectionsofthehipandkneeJ．JBoneJointSurgAm2011931355－1357．4MinassianAMOsmonDＲBerendtAＲetal．ClinicalguidelinesinthemanagementofprostheticjointinfectionJ．JAntimicrobChemother201469i29－i35．5OsmonDＲBerbariEFBerendtAＲetal．DiagnosisandmanagementofprostheticjointinfectionclinicalpracticeguidelinesbytheInfectiousDiseasesSocietyofAmericaJ．ClinInfectDis201356e1－e25．6TandeAJPatelＲ．ProstheticjointinfectionJ．ClinMicrobiolＲev201427302－345．7ShumanEKUrquhartAMalaniPN．ManagementandpreventionofprostheticjointinfectionJ．InfectDisClinNAm201229－39．8．J/CD．20148817－819．9．M．2001200．10LewDPWaldvogelFA．OsteomyelitisJ．Lancet2004364369－379．11WaldvogelFAMedoffGSwartzMN．OsteomyelitisareviewofclinicalfeaturestherapeuticconsiderationsandunusualaspectsJ．NEnglJMed1970282198－206．12WaldvogelFAMedoffGSwartzMN．OsteomyelitisareviewofclinicalfeaturestherapeuticconsiderationsandunusualaspectsJ．NEnglJMed1970282316－322．13CiernyG3rdMaderJTPenninckJJ．AclinicalstagingsystemforadultosteomyelitisJ．ClinOrthopＲelatＲes20034147－24．14KimYIKimSEJangHCetal．AnalysisoftheclinicalcharacteristicsandprognosticfactorsofinfectiousspondylitisJ．InfectChemother20114348－54．15CarekPJDickersonLMSackJL．DiagnosisandmanagementofosteomyelitisJ．AmFamPhysician2001632413－2420．16LewDPWaldvogelFA．OsteomyelitisJ．NEnglJMed1997336999－1007．17DirschlDＲAlmekindersLC．Osteomyelitis．CommoncausesandtreatmentrecommendationsJ．Drugs19934529－43．18ChoudhryＲＲＲiceＲPTriffittPDetal．PlasmaviscosityandC-reactiveproteinaftertotalhipandkneearthroplastyJ．JBoneJointSurgBr199274523－524．19VisserMBouterLMMcQuillanGMetal．ElevatedC-reactiveproteinlevelsinoverweightandobeseadultsJ．JAMA19992822131－2135．20ZimmerliWTrampuzAOchsnerPE．Prosthetic-jointinfectionsJ．NEnglJMed20043511645－1654．21SantiagoＲestrepoCGiménezCＲMcCarthyK．ImagingofosteomyelitisandmusculoskeletalsofttissueinfectionscurrentconceptsJ．ＲheumDisClinNorthAm20032989－109．22PakosEEKoumoullisHDFotopoulosADetal．Osteomyelitisantigranulocytescintigraphywith99mTCradiolabeledmonoclonalantibodiesfordiagnosis--meta-analysisJ．Ｒadiology2007245732－741．23TermaatMFＲaijmakersPGScholtenHJetal．Theaccuracyofdiagnosticimagingfortheassessmentofchronicosteomyelitisasystematicreviewandmeta-analysisJ．JBoneJointSurgAm2005872464－2471．25ParsonsBStraussE．SurgicalmanagementofchronicosteomyelitisJ．AmJSurg200418857－66．26WaldvogelFAPapageorgiouPS．OsteomyelitisthepastdecadeJ．NEnglJMed1980303360－370．27CalhounJHManringMM．AdultosteomyelitisJ．InfectDisClinNorthAm200519765－786．28LeachＲMＲeesPJWilmshurstP．HyperbaricoxygentherapyJ．BrMedJ19983171140－1143．29DavisJCHeckmanJDDeLeeJCetal．Chronicnon-hematogenousosteomyelitistreatedwithadjuvanthyperbaricoxygenJ．JBoneJointSurgAm1986681210－1217．30BerendtAＲ．CounterpointhyperbaricoxygenfordiabeticfootwoundsisnoteffectiveJ．ClinInfectDis200615193－198．31BrookIFrazierEH．Anaerobicosteomyelitisandarthritisinamilitaryhospitala10-yearexperienceJ．AmJMed19939421－28．32WestonVCJonesACBradburyNetal．ClinicalfeaturesandoutcomeofsepticarthritisinasingleUKHealthDistrict1982－1991J．AnnＲheumDis199958214－219．33G